| Hans-Günter Meyer-Thompson | Verschiedenes
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.
Scott TM, Arnsten J, Olsen JP, Arias F, Cunningham CO, Rivera Mindt M.
Addict Sci Clin Pract. 2021 Oct 24;16(1):64. doi: 10.1186/s13722-021-00272-4. PMID: 34689841; PMCID: PMC8543954.